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“Ninguém aprende a andar de bicicleta 
sem cair primeiro!”  
“Nobody learns how to ride a bike 
without falling first!” 
by JMCC 
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RESUMO  
O ácido retinoico (AR) é um morfogénio derivado da vitamina A, que a 
par com outras vias de sinalização (e.g. factores de crescimento de 
fibroblasto (FGF), fatores de crescimento de transformador beta (TGF-β), 
Sonic hedghog (Shh) e Wnt) está envolvido diretamente no 
desenvolvimento embrionário sendo, por exemplo, fundamental na 
especificação do eixo ântero-posterior durante fases precoces da 
embriogénese. A transdução de sinal da via do AR é feita principalmente 
através de duas famílias de recetores nucleares, os recetores X de 
retinoides (RXR) e os recetores de ácido retinoico (RAR). Classicamente, 
estes recetores atuam sob a forma heterodimérica ligando-se 
especificamente a regiões promotoras, no ADN. Estas regiões são 
denominadas elementos de resposta ao ácido retinoico (RARE) e são 
tipicamente caracterizadas pela dupla repetição da sequência conservada 
(A/G)G(G/T)TCA, ou na forma mais relaxada (A/G)G(G/T)(G/T) (G/C)A, e 
encontram-se normalmente separadas por um, dois ou cinco nucleótidos. O 
heterodímero RXR/RAR encontra-se normalmente ligado ao promotor 
específico, mas na ausência de ligando este recruta um complexo co-
repressor, o qual é responsável pela condensação da cromatina e, 
consequentemente, pela repressão da expressão génica. Na presença do 
AR, este liga-se ao complexo RXR/RAR no qual induz uma alteração 
conformacional o que, por sua vez, leva ao recrutamento de co-activadores 
permitindo a descondensação da cromatina e a ligação do complexo de pré-
iniciação da transcrição à região do promotor. 
O AR é endogenamente sintetizado através de um processo que consiste 
em duas oxidações. A primeira é reversível e origina retinaldeído a partir de 
vitamina A, também conhecida como retinol. Esta reação é levada a cabo 
por enzimas da família das desidrogenases de álcoois e por membros da 
família das desidrogenases de retinol. A segunda oxidação é uma reação 
irreversível e transforma o retinaldeído em AR, sendo as desidrogenases de 
retinaldeído as principais enzimas envolvidas nesta reacção. Além disso, a 
biodisponibilidade de AR é regulada ao nível da degradação. Este processo é 
principalmente controlado por enzimas da família de citocromos P450 
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subfamília 26 (Cyp26) e transforma AR em metabolitos biologicamente 
menos ativos. 
Até um passado bastante recente, a via AR foi tida como exclusiva na 
linhagem dos vertebrados. Porém, estudos mais recentes demonstraram 
que está presente nas diferentes linhagens de cordados (vertebrados, 
tunicados e cefalocordados). Por outro lado, estudos recentes recorrendo a 
bioinformática levaram a que a origem evolutiva da via de sinalização do AR 
fosse alterada uma vez mais, dada a existência de genes ortólogos a 
componentes básicos desta via em ambulacrários e lofotrocozoários. Assim 
sendo, a sinalização por AR tem provavelmente a sua origem na base dos 
bilatérios. Assim, para um escrutínio detalhado da evolução da via de 
sinalização do AR e dos seus mecanismos reguladores, o cefalocordado 
anfioxo (B. lanceolatum) foi usado como modelo animal. Este revelou-se o 
modelo adequado uma vez que possui uma morfologia e um genoma típicos 
de vertebrados carecendo, no entanto, de caracteres morfológicos e 
genómicos associados a inovações obtidas por vertebrados ao longo da 
evolução como as células da crista neural e a duplicações completas do 
genoma. Apesar de a maior parte dos estudos que abordam a temática do 
ácido retinoico, em anfioxo, se focar em genes alvo ativados pelo seu único 
par heterodimérico RXR/RAR, poucas foram as abordagens para revelar 
como é controlada a biodisponibilidade do AR durante o desenvolvimento 
embrionário. 
Este projecto ambicionou revelar um pouco mais sobre o controlo 
endógeno de AR, tendo como principal objetivo perceber como é que as três 
enzimas Cyp26 de anfioxo interagem ao longo do desenvolvimento de 
forma a controlarem as regiões de influência deste morfogéneo.  
Com o objectivo de entender as relações filogenéticas entre os diversos 
genes Cyp26 em bilatérios, foram realizadas análises in silico contemplando 
informação genómica, nomeadamente a cadeia de aminoácidos destas 
enzimas. Para a caracterização do padrão de expressão dos três genes 
Cyp26 durante o desenvolvimento do anfioxo foi utilizada a técnica de 
hibridação in situ, a qual marca mARN específico através de sondas de ARN, 
permitindo inferir a expressão de determinado gene. Adicionalmente, a 
técnica de PCR quantitativo em tempo real permitiu analisar 
quantitativamente a expressão dos genes de interesse. O objectivo foi 
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analisar detalhada e informativamente a variação da expressão de Cyp26-1, 
Cyp26-2 e Cyp26-3 em diferentes pontos do desenvolvimento embrionário, 
num estádio de diferenciação neural e num estádio larvar. 
Complementarmente e de forma a estudar a influência de AR, uma análise 
quantitativa foi também realizada em embriões submetidos a tratamentos 
farmacológicos com AR e BMS009, um antagonista da sinalização por AR. 
Em simultâneo, embriões submetidos a tratamentos farmacológicos foram 
analisados de forma a visualizar os locais de ocorrência de transcrição de 
Cyp26s recorrendo, uma vez mais, à técnica de hibridação in situ. 
Os resultados aqui apresentados revelam, em simultâneo, dados 
interessantes e limitações que futuramente devem ser contornadas. Do 
ponto de vista evolutivo, a nossa análise filogenética revela que as 
sequências de Cyp26 de vertebrados incluídas na análise, devido ao seu 
arranjo na árvore obtida, recapitulam as duplicações completas do genoma 
descritas durante a diversificação deste grupo. Adicionalmente, o arranjo 
filogenético para os genes de anfioxo sugerem que estes terão sido 
originados através de uma duplicação específica de linhagem ocorrida em 
cefalocordados. O padrão de expressão dos genes Cyp26 de anfioxo 
apresenta um arranjo bastante complexo, quer em termos espaciais quer 
em termos temporais: ambos os Cyp26-1 e Cyp26-3 apresentam uma 
expressão bastante pouco marcada e que aparenta ser restrita a estruturas 
mesodermais. Por oposição, Cyp26-2 apresenta uma expressão bastante 
evidente desde uma fase incial do desenvolvimento (gastrulação) que se 
mantem até a um estado larvar avançado. Este gene é expresso 
maioritariamente em duas regiões: posteriormente, onde deverá ser 
responsável por criar um ambiente permissivo para as células do blastóporo 
antes da neurulação e numa fase tardia, onde estará envolvido na 
especificação de estruturas ectodermais da cauda; e anteriormente, onde a 
sinalização é fundamental para evitar os efeitos deletérios do AR na 
especificação de estruturas anteriores, derivadas de todas as camadas 
germinativas e sendo, mais tarde no desenvolvimento, essencial para a 
degradação do AR em estruturas derivadas da faringe, tal como a boca. 
Combinando as informações obtidas através de qRT-PCR numa situação 
controlo e em embriões submetidos a tratamentos de AR e BMS009 com o 
padrão de expressão obtido com a técnica de hibridação in situ sob as 
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mesmas condições farmacológicas, é possível sugerir que todos os Cyp26 
de anfioxo estão sob o controlo AR, embora nem todos apresentem a 
mesma sensibilidade. Concomitantemente, Cyp26-2 aparenta ser o principal 
regulador da padronização dependente da degradação de AR durante o 
desenvolvimento embrionário e, por sua vez, Cyp26-1 e Cyp26-3 devem 
efetivamente apresentar uma função quase nula no que toca a este 
capítulo. No entanto, devem ser as principais enzimas recrutadas no caso 
de uma situação na qual exista excesso de retinóides. Assim, estes dois 
genes parecem ter desenvolvido uma função marginal que funciona como 
um tampão interno para a manutenção da homeostasia de AR. 
Em suma, este estudo apresenta as primeiras evidências experimentais 
do envolvimento de Cyp26s no desenvolvimento embrionário de anfioxo 
revelando, simultaneamente, novos detalhes sobre a história evolutiva da 
cascata de sinalização do AR. 
 
Degradação de ácido retinóico, Cefalocordados, Duplicação específica de 
linhagem, Evolução, Desenvolvimento 
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ABSTRACT  
Retinoic acid (RA) is a potent morphogen, derived from vitamin A, which 
exhibits crucial functions during development. Transduction of the RA signal 
is driven by two nuclear receptors, working as heterodimers, the retinoid X 
receptor (RXR) and the retinoic acid receptor (RAR), that are responsible for 
activation of the transcription of target genes. Endogenous RA is 
synthesized by the irreversible oxidation of retinal to RA by retinaldehyde 
dehydrogenases, and is degraded by Cyp26 enzymes. Initially described as 
being specific to vertebrates and subsequently to chordates, recent in silico 
studies locate the evolutionary origin of the RA signaling cascade at the 
base of the bilaterian animals. 
To fully understand the evolution of RA signaling as well as the 
mechanisms governing its developmental functions, the cephalochordate 
amphioxus constitutes an ideal model. Amphioxus is characterized by a 
vertebrate-like morphology and genome, yet lacking key morphological 
innovations of vertebrates, such as definite a neural crest, and the whole 
genome duplications characterizing vertebrates. Most studies on RA 
signaling in amphioxus have focused on the targets activated by the single 
amphioxus RXR/RAR heterodimer and not much is known about the 
bioavailability of endogenous RA in the amphioxus embryo. 
Here, we address this question from the perspective of RA degradation. 
We demonstrate that, in amphioxus (Branchiostoma lanceolatum), there are 
three Cyp26 genes which have originated by lineage-specific duplication. In 
situ hybridization studies show that only one of the three Cyp26 paralogs is 
characterized by conspicuous developmental expression indicating that it 
may single-handedly mediate the majority of Cyp26-dependent 
developmental patterning functions. Concomitantly, qPCR analyses suggest 
that the lineage-specific duplication of Cyp26 genes, which has occurred in 
the cephalochordates, might have contributed to the development of a 
mechanism that controls and avoids the teratogenic effects associated with 
excess or lack of endogenous RA. 
 
Retinoic acid degradation, Cephalochordates, Lineage-specific duplication, 
Evolution, Development   
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I. INTRODUCTION  
i. General topics in Evolutionary Developmental Biology 
Developmental biology studies focus on a highly complex question: how 
to create an entire organism from a single cell? Classically and due to the 
complexity inherent to this question, it has been approached from three 
different perspectives: differentiation, morphogenesis and growth1. 
Differentiation, once an initial fertilized egg gives rise to different germ 
layers, which by themselves will derive to different specialized cell types1; 
morphogenesis since it is, by definition, the biological process responsible 
for the rearrangement of these cells to form functional structures (organs) 
that later will be structured to create an entire functional organism1; and 
growth is the paradigmal driving force of expansion of structures, which 
exhibit a very tight regulation, both spatial and temporal1. All together, 
these forces drive this initial cell through the long journey of development. 
A step forward in the understanding of the remarkable process of 
embryogenesis was the adoption of the emerging tools of molecular biology. 
These new tools revealed the involvement of a relatively small number of 
different signaling pathways. The morphogens, receptors and transcription 
factors included in these cascades are considered the master regulators of 
development. Family members of the ﬁbroblast growth factor (FGF), 
wingless/Wnt (Wnt), hedgehog (Hh), transforming growth factor beta (TGF-
β) and retinoic acid (RA) signaling pathways are correlated differentially in 
different cellular backgrounds, yielding specific functions. In general, 
embryological processes are very tightly controlled, mostly through 
elaborate autoregulatory loops in combination with refined interactions 
between these master signaling cascades1. 
More recently, development has coupled its questions with a different 
field, evolutionary biology. This fusion built a bright new area named 
evolutionary developmental biology (Evo-Devo) that uses developmental 
biology as a system to study morphological evolution1. The final aim of Evo-
Devo studies is the design of evolutionary hypoteses able to explain 
evolution of morphologies, based on the comparison of developmental 
mechanisms between species. 
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ii. Evo-Devo and Retinoic Acid 
Under an Evo-Devo perspective, where modifications of embryonic 
development can prompt changes in the body plan of animal species (Fig. 
1), the in depth study of the RA cascade might contribute with interesting 
elements. 
RA, more specifically its all-trans conformation, is now generally 
accepted as the main biologically active form of vitamin A. Vitamin A itself is 
described as the main precursor of a group of fat-soluble morphogens that 
enclose functions in fundamental biological processes, ranging from early 
development to immune functions, including organogenesis, tissue 
homeostasis, proliferation, differentiation, apoptosis and vision2-10. 
Together with the uncountable functions of retinoids, recent studies 
point to the origin of the RA signaling cascade far earlier in evolution than 
was initially assumed. The original idea of a vertebrate-specific signaling 
pathway has been proven wrong by work carried out in tunicates and 
cephalochordates11. Moreover, recent in silico analyses have revealed the 
existence of the molecular components of vertebrate RA signaling cascades 
outside of chordates7,12. From an evolutionary perspective, the most striking 
discovery from this body of work is that orthologs of the key players of RA 
signaling exist in both ambulacrarians and lophotrochozoans, showing that 
RA signaling might have already been present in the last common ancestor 
between protostomes and deuterostomes7,12. 
 
iii. Retinoic Acid Synthesis, Degradation and Trafficking  
The main source of retinoids in animals is diet dependent, as these 
compounds cannot be synthesized de novo. In vertebrates, Vitamin A 
(retinol) binds to retinol binding protein (RBP), a specific transport protein, 
and this complex is directed to target tissues13 (Fig. 2). Considering that 
RBP is the only known specific carrier of retinol, mice lacking RBP have 
brought unexpected information since neither viability nor morphology are 
compromised when they are exposed to a vitamin A-sufficient diet14. 
Furthermore, a fraction of circulating soluble RBP is associated one-to-one 
with another serum protein, transthyretin (TTR)15,16. Cellular uptake of 
circulating retinol complex is mediated by a RBP membrane receptor called 
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Stimulated by Retinoic Acid 6 (STRA6)17 (Fig. 2). This receptor works as 
bidirectional retinol transporter, with the internal state of retinoids being 
responsible for the control of its activity13. 
After entering the cell, retinol is transformed to RA by a canonical 
pathway characterized by a two-step oxidation. The first oxidation 
represents a reversible reaction that generates retinaldehyde and is carried 
out by enzymes of two different classes: the cytosolic alcohol 
dehydrogenases (ADHs) that belong to the medium-chain 
dehydrogenase/reductase family and microsomal retinol dehydrogenases 
(RDHs), members of the short-chain dehydrogenase/reductase group18. The 
ADH family consists of numerous enzymes with three (ADH1, 3 and 4) 
highly conserved paralogs in vertebrates19. In extreme conditions of retinoid 
Fig. 1 – Simplified schematic phylogenetic tree of the metazoans. Adapted from 
Campo-Paysaa et al. Genesis 2008 
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supply, both deficiency and excess, ADH1 and 4 have been suggested as 
the main players involved in the first oxidation step, while ADH3 seems to 
function continously8. Moreover, genetic studies in mice have shown that 
loss of function of RDH10 is embryonic lethal20, showing that this enzyme is 
essential for RA generation in the developing21 (Fig. 2).  
The second reaction that leads, ultimately, to RA production is 
characterized by the conversion of retinaldehyde during an irreversible 
oxidation by retinaldehyde dehydrogenase (RALDH) (Fig. 2). There are 
three main paralog genes characterized, RALDH1, RALDH2 and RALDH3, 
each with distinct expression patterns6,22. In vertebrates, RALDH2 is present 
in very early development and plays a crucial role in early embryogenesis23-
26. In contrast, RALDH1 and RALDH3 are expressed later during 
development and they greatly contribute to the patterning of the respiratory 
and visual systems27,28. 
Alternatively, recent data suggest that RA synthesis can also occur 
through an alternative process by action of cytochrome p450 family of 
mono-oxygenases2. CYP1B1 has emerged as a very likely candidate, since it 
is able to efficiently oxidize retinol into retinaldehyde and subsequently to 
RA, in vitro, and its expression pattern is consistent with RA synthesis 
during embryogenesis29.  
In addition to RA synthesis, endogenous RA degradation is tightly 
regulated in space and time during development. This process is mainly 
driven by proteins of the cytochrome p450 family, chiefly CYP26 enzymes30. 
Vertebrates possess three Cyp26 paralogs, Cyp26A1, Cyp26B1 and 
Cyp26C1, all of which have very well characterized expression patterns31,32. 
This family of enzymes promotes the catabolism of RA by production of 
polar metabolites, including 4-hydroxy RA, 4-oxo RA, 18-hydroxy RA, 5,6-
epoxy RA or 5,8-epoxy RA33. The question of the biological relevance of 
these metabolites as signaling molecules is still unclear34 (Fig. 2). 
Within cells, RA activity is also modulated by proteins that bind to 
retinol and RA, the so called cellular retinol binding proteins (CRBPs) and 
cellular retinoic acid binding proteins (CRABPs)35 (Fig. 2). In vertebrates, 
there are two CRBP paralogs, CRBP-I and CRBP-II, that possess very 
divergent expression patterns35. CRBP-I has high affinity for its substrate 
allowing a faster uptake of free circulating retinol, indicating its function as 
7 
 
key player in the conversion of retinol into retinaldehyde and as regulator of 
retinol storage. CRBP-II is essentially present in cells of the small intestine, 
suggesting an involvement in the processing of retinol taken up from food. 
There are also two CRABP paralogs, CRABP-I and CRABP-II, and these two 
proteins also exhibit distinct temporal and spatial expression profiles35. 
During embryonic development both are widely expressed, however, their 
expression does not overlap contrasting with the adult stages where CRABP-
I expression is almost ubiquitous. CRABP-II has been suggested to be 
responsible for the transport of RA to RAR in the nucleus, fact supported by 
Fig. 2 – Overview of retinol metabolism and signaling. Schematic view of the 
conversion of retinol into its major active metabolite, retinoic acid, and activation of retinoid-
dependent signaling. ADH, alcohol dehydrogenase; CRABP, cellular retinoic acid binding 
protein; CRBP, cellular retinol binding protein; CYP26, cytochrome P450 family 26; RA, 
retinoic acid; RALDH, retinaldehyde dehydrogenase; RAR, retinoic acid receptor; RARE, 
retinoic acid response element; RBP, retinol binding protein; RDH, retinol dehydrogenases; 
RXR, retinoid X receptor; STRA6, stimulated by retinoic acid gene 6; TTR, transthyretin. 
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the increase of RA signaling when CRABP-II is overexpressed in the frog 
Xenopus laevis36, as well as in cell lines37. In contrast, CRABP-I seems to 
deliver RA to degradation38.  
 
iv. RA Signaling Integration, the Paradigm of the RXR/RAR 
Heterodimer 
RA exerts its effects through direct binding to nuclear receptors, 
classically in association with the heterodimer RXR/RAR (retinoid X 
receptor/retinoic acid receptor)39. In vertebrates, there are three paralogs 
of each receptor (α, β and γ)40. RXR and RAR bind as heterodimers to DNA 
in the promoter regions of target genes. After the association of RA and RAR 
a conformational change is induced in the receptor heterodimers allowing 
gene-specific transcription41. The RXR/RAR heterodimer interact with 
specific DNA regions, the retinoic acid response elements (RARE) (Fig. 2). 
These RAREs typically comprise two direct repeats (DRs) with the conserved 
nucleotide sequence (A/G)G(G/T)TCA or of the more relaxed sequence 
(A/G)G(G/T)(G/T)(G/C)A  spaced by one, two or five nucleotides (DR1, DR2 
or DR5, respectively)40,42,43. Different RAREs have been identified in 
promoters of different RA-target genes involved in a wide variety of 
biological functions42. According to the canonical model, in absence of the 
ligand RXR/RAR can bind DNA associated with a co-repressor complex 
NCOR/Sin3A/HDAC, responsible for chromatin compaction and therefore 
target gene repression44. In the presence of ligand, due to a conformational 
change within the receptor, there is release of co-repressors and 
recruitment of co-activator complexes, leading to a decondensation of the 
chromatin and allowing the assembly of the transcription pre-initiation 
complex28. Several recent studies have shown that the specific activation 
mechanisms of gene transcription programs triggered by RARs are 
dependent on the target gene promoter45. 
 
v. RA Functions during Embryonic Development 
During vertebrate development, RA exhibits pleiotropic effects, but 
these outputs are not only RA dependent, they are also the result of 
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interactions with several pathways (FGF, Shh, Wnt and TGF-β). Crosstalk 
between RA and these pathways can display very different architectures: 
they can be synergistic or antagonistic, may act directly or through indirect 
signaling, and can involve one or several regulatory loops46. 
Vertebrate embryos treated with exogenous RA lose/reduce a part of 
the forebrain/midbrain and there is a clear extension of the hindbrain47-50. 
Thus, RA function seems fundamental for the establishment of positional 
information in the central nervous system5. Hox genes are intimately 
associated with the establishment of positional information during 
development of the hindbrain51, with the establishment of the Hox code 
itself controlled by RA signaling 52. A very dynamic arrangement of RA 
sources, RALDH2, and sinks, Cyp26, regulate the activation or inhibition of 
specific Hox genes in the hindbrain. FGF information provided by the 
midbrain and posterior CNS is alsoinvolved in the process53-56. Retinoid 
signaling is also important for specification of interneurons and motor 
neurons across the DV axis during development52. In the spinal cord, RA 
interacts with Shh to establish ventral determinants by induction of genes 
governing the dorsal-ventral (DV) patterning57. In absence of RA, the 
ventral neurons are not induced to differentiate from the neuroectoderm of 
the spinal cord57,58. Neurite outgrowth is also controlled by RA during 
development, since a lack of RA signaling is responsible for abnormal axonal 
projections50,59. 
RA signaling plays a fundamental role in AP axis specification, not only 
in the CNS, but also of the mesoderm. For example, the expression of 
Cyp26 is suppressed by FGF and Wnt signaling, which are involved in the 
specification of posterior trunk fate60. Moreover, RA is probably also 
involved in a side-specific activation of genes involved in LR specification, 
such as lefty, pitx and nodal61-63. However, RA action during somitogenesis 
is associated with maintenance of somites symmetric formation along the 
LR axis64,65. Here, RA works as a buffer that is able to balance and prevent 
LR asymmetry signaling of occurring in presomitic mesoderm (PSM), which 
later gives rise to lateral plate mesoderm specification65. Additionally, RA 
signaling is an important mediator of cardiac field specification, patterning 
of the AP axis of the heart tube and heart looping23,66-68. Interestingly, the 
role of RA in heart patterning is well conserved within vertebrates, as 
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exogenous supplementation leads to similar defects in mice69, zebrafish70 
and chicken71. In this context, RALDH2 is expressed in the PSM and later in 
the lateral mesoderm creating a wave of RA that generates cardiac 
precursors and delimitates the heart field along the AP axis71. 
RA also participates in limb development where it is required during 
forelimb induction, but it is dispensable at later stages when hindlimb 
budding and patterning are established72. The action of RA seems to be 
indirect once it generates a FGF permissive environment that allows 
development of limb buds72.  
RA signaling is also involved in specification and establishment of 
different endodermal fields. Exposure to exogenous RA prevents the 
expression of genes normally present in the anteriormost endoderm, while 
at the level of the pharyngeal arches gene expression is activated and 
expanded anteriorly73. Interestingly, when RA signaling is disrupted there 
are no effects in the first and second pharyngeal arches, but severe defects 
are observed in structures derived from more posterior pharyngeal arches74. 
Some organs derived from the endoderm of the posterior foregut also 
require RA for proper development, like lungs, stomach, liver and pancreas. 
Lack of RA signaling causes a disruption of lung bud outgrowth since FGF10, 
one of the main players in branching morphogenesis (in parallel with BMP4), 
is absent. In addition, development of stomach and liver requires the 
control of FGF signaling by RA75. Furthermore, absence of RA signaling is 
responsible for the specific inhibition of pancreas development, by 
disturbing the patterning of its presumptive dorsal bud76,77. 
RA interacting with FGF signaling also acts to regulate the epithelial-
mesenchymal transition of neural crest cells (NCC)78. RA also has a role in 
differentiation of NCC populations during gastrulation events79 and in the 
specification of placodes. RA has been shown to have a role in the 
establishment of in the otic80, optic81, olfactory82, and lateral line placodes83. 
Altogether, the above description illustrates that the RA signaling 
system of vertebrates as well as most of its functions are very well 
described (Fig. 3). However, relatively little is known about the evolution of 
this signaling cascade. 
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vi. The Beast and the Beauty: Amphioxus as a Model System  
The phylum Chordata comprises three extant groups: cephalochordates 
(amphioxus), urochordates (tunicates) and vertebrates. Due to recent data 
provided by genomic sequencing and molecular phylogeny, the Chordate 
phylogeny has undergone a considerable change with the proposition that 
urochordates and not cephalochordates as the sister group of vertebrates84. 
Despite this fact, cephalochordates maintain an important position for 
studies that address Chordate diversification. 
One of the main arguments for this leading role concerns the adult body 
plan of amphioxus. It exhibits striking similarities with the vertebrate body 
plan, while in tunicates the body plan is more derived and has probably lost 
some chordate-specific traits84,85. For example, cephalochordates and 
vertebrates share a hollow nerve cord dorsal to a notochord, a postanal tail, 
pharyngeal gill slits and an endostyle (a thyroid gland homologue)85. 
However, there are vertebrate-specific characters missing, like paired 
sensory organs, a cartilaginous or bony skeleton, definitive neural crest cells 
and a morphologically differentiated brain86. In early embryonic 
Fig. 3 – Overview of RA roles during vertebrate embryonic development. Schematic 
view of two different stages of vertebrate development, with development of the highlighted 
being influenced by RA. 
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development, despite some major differences, amphioxus and vertebrates 
share very specific features. The embryo of amphioxus has thus been 
proposed to be a realistic approximation of the stem chordate embryo, 
before the evolution of specific cleavage mechanisms in the tunicates and 
the evolution of large amounts of yolk in basal vertebrates87. 
Recent developments in genomic analysis have indicated that 
amphioxus possesses an archetypal vertebrate genome lacking whole 
genome duplications88, contrasting with the massive gene losses and 
genome rearrangements associated with urochordate genomes89,90. That 
said, the amphioxus genome does exhibit an expansion of several specific 
gene families that, most likely, do not represent ancestral characters. For 
example, families of genes encoding opsins, ALDHs and SDRs, together with 
several homebox genes, have undergone lineage-specific expansions in 
cephalochordates85,91-93. Apart from this divergence of gene families the 
genomes of cephachordates and vertebrates also exhibit an extensive 
conservation of syntenic regions and gene linkage88. 
The subphylum Cephalochordata is divided into three genera: 
Asymmetron, Epigonychthys and Branchiostoma94. Cephalochordates can 
generally be found in the majority of the coastal regions on every continent 
in relatively shallow marine habitats, burrowing tail-first in the sand and 
filter-feeding95. The majority of the work on cephalochordates has been 
carried out on four Branchiostoma species: the European amphioxus (B. 
lanceolatum), the Florida amphioxus (B. floridae), the Chinese amphioxus 
(B. belcheri) and the Japanese amphioxus (B. japonicum). All four 
amphioxus species present seasonal reproduction periods96,97. After external 
fertilization, amphioxus embryos and larvae live in shallow marine water 
until they undergo metamorphosis, which is characterized by several 
anatomical remodeling events turning the asymmetric larva into a quasi-
symmetric juvenile. After metamorphosis, the amphioxus juveniles alter 
their lifestyle and become benthic in predominantly sandy habitats98. 
Improvements of embryo acquisition and culture have enabled great 
advances in the development of amphioxus as a usable model to study the 
evolution of chordates, and particularly the evolution of developmental 
processes in this phylogenetic branch99. Thus, it is now possible to maintain 
13 
 
adult amphioxus in an artificial sea water system and induce on-demand 
spawning independent from environmental stimuli100. 
 
vii. RA Signaling in Amphioxus 
An approach combining treatments with RA or RA antagonist together 
with marker gene expression studies yielded a rather detailed description of 
the roles of RA signaling during amphioxus development. In the amphioxus 
central nervous system it was shown that RA regulates the expression of 
key players of AP regional patterning, in particular Hox genes. The domains 
of Hox1, Hox2, Hox3, Hox4 and Hox6 are expanded anteriorly when RA is 
added, while RA antagonist shifts the Hox gene expression domains 
posteriorly101. Likewise, RA strongly upregulates RAR expression, while RA 
antagonist has the inverse effect102. Also exogenous RA promotes the loss 
of pharyngeal structures whereas RA antagonist treatments yield the 
opposite outcome103. Morpholino-based functional knockdown experiments 
suggest that this role of RA signaling in establishing the posterior limit of 
the pharynx is directly mediated by Hox1103. Additionally, it has also been 
shown that RA and RA antagonist alter the expression domains of Hox 
genes in the general ectoderm104. Moreover, in the posterior endoderm, RA 
signaling controls the expression of two ParaHox genes, Xlox and Cdx, 
hence mediating AP patterning of the developing amphioxus hindgut105.  
Altogether, these data have established that RA, acting via Hox genes, is 
crucial for AP patterning of the amphioxus early embryo and that this RA-
Hox signaling hierarchy plays further, tissue-specific roles, in patterning of 
the central nervous system, general ectoderm and endoderm106, although 
more details on the regulation of amphioxus ParaHox genes by RA must be 
assessed105. 
Albeit the existence of rather detailed concepts about the functions of 
RA signaling during amphioxus development, with the exception of a study 
on RA synthesizing enzymes93, virtually nothing is known about the 
mechanisms controlling the establishment of RA reactive zones in the 
amphioxus embryo. There is, thus, a necessity to study the most 
fundamental components of the RA pathway, including RA binding proteins 
and enzymes capable of synthesizing and degrading endogenous RA, to 
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assess RA signaling activity in the developing embryo. Detailed data on 
these key components together with information provided by studies carried 
out in vertebrates will unravel conserved and/or divergent elements of RA 
signaling cascade, which in turn will allow the reconstruction of the 
evolutionary diversification of this morphogen-dependent signaling pathway 
in chordates. 
 
viii. Objectives 
As previously mentioned, the detailed study of central components of 
the RA signaling pathway can provide novel insights into the evolutionary 
diversification of the RA cascade in chordate evolution. In this context, 
degradation is of vital relevance for RA homeostasis, a process driven by 
Cyp26 enzymes, which show a very tight regulation30,53. In vertebrates, the 
three Cyp26 paralogs present a non-overlaping spatiotempotal expression30, 
suggesting that each one of them as a specific function during embryonic 
development, probably tissue-specific. For example, Cyp26 mutants exhibit 
severe malformations, such as spina bifida, limb truncations, cerebral 
dystrophy, caudal regression and respiratory complications after birth30. 
Here, we aim to understand how expression of RA degradation enzymes 
(Cyp26) can be correlated with RA distribution and functions during 
amphioxus (B. lanceolatum) embryonic development.  
To address this question the genes encoding Cyp26 enzymes in B. 
lanceolatum were cloned and the evolutionary history of Cyp26 genes 
analyzed by phylogenetic tree reconstruction. Moreover, expression 
patterns of the amphioxus Cyp26 genes were characterized in detail during 
development by in situ hybridization (ISH) and expression at key points of 
development was subjected to quantitative analyses using qRT-PCR. 
Moreover, the expression patterns were also studied under specific 
pharmacological conditions, such as RA and BMS009 (a RA antagonist) 
treatments. 
Altogether this work sheds new light on the evolutionary diversification 
of the Cyp26 family and highlights conserved and divergent aspects of the 
regulation of endogenous RA levels during development. 
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II. MATERIAL AND METHODS 
i. Phylogenetic Analysis  
For the phylogenetic analysis the following list of amino acid sequences 
has analysed (accession number, and genome web browseres are given 
with the sequence names): Lottia gigantea Cyp51: 108695; L. gigantea 
Cyp26: 111029 and 189041 from the genome database (http://genome.jgi-
psf.org/Lotgi1/ Lotgi1.home.html). Capitella teleta Cyp51: 173561; C. 
teleta Cyp26: 150007 and 212322 (http://genome.jgi.doe.gov/Capca1 
/Capca1.home.html). Strongylocentrotus purpuratus Cyp51: SPU_025595 
(http://urchin. nidcr.nih.gov/) S. purpuratus Cyp26: XP_001194704. 
Saccoglossus kowalevskii Cyp26s: NP_001161524 and XP_002734884. 
Branchiostoma floridae Cyp26s: XP_002588109, XP_002588110 and 
XP_002588112 (http://www.ncbi.nlm.nih.gov/). Gasterosteus aculeatus 
Cyp26s: ENSGACP00000020277 ENSGACP00000024870 and 
ENSGACP00000014 658. Tetraodon nigroviridies Cyp26s: 
ENSTNIP00000007321, ENSTNIP0000 0014173 and ENSTNIP00000021864. 
Oryzias latipes Cyp26s: ENSORLP0000 0018194, ENSORLP00000004308 
and ENSORLP000 00002541 Gallus gallus Cyp26s: ENSGALP00000010871, 
ENSGALT000000 25943 and ENSGALP00000010878 
(http://www.ensembl.org/index.html). Danio rerio Cyp51: AAR89625; D. 
rerio Cyp26s: NP_571221, NP_997831 and NP_001025122. Xenopus 
tropicalis Cyp26s: NP_001016147, NP_001072655 and XP_002939137. 
Monodelphis domestica Cyp26s: XP_001375292 and XP_001375317. Homo 
sapiens Cyp51: EAL24154; H. sapiens Cyp26s: NP_000774, NP_063938, 
NP_899230. Mus musculus Cyp26s: NP_031837, NP_780684 and 
NP_001098671 (http://www.ncbi. nlm.nih. gov/). Ciona intestinalis Cyp26s: 
ENSCINP00000009998, ENSCINP00000024552. Ciona savignyi Cyp26s: 
ENSCSAVP00000003718 and ENSCSAVP00000003583. 
The sequences were aligned with Clustal as implemented in Seaview107 
and refined by eye, the final alignment comprises 661 positions. The 
molecular phylogeny was reconstructed by Maximum Likelihood (ML) with 
Phyml108 under the model JTT. The robustness of the node was estimated by 
bootstrap (1000 pseudoreplicates) with Phyml. Cyp51 has used as 
outgroup. 
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ii. Maintenance and Spawning of Amphioxus in the 
Laboratory 
Sexually mature animals of the Mediterranean amphioxus (B. 
lanceolatum) were collected by dredging at Argelès-sur-Mer, France, and 
retrieved from the sand with a sieve96,97. Following the collection, adult 
animals were transported to an artificial sea water facility and then 
transferred into their respective tanks. All the animals collected were 
divided accordingly, about 10-15 animals per tank (2,7 L of maximal 
capacity), both males and females together. Each tank contained a layer of 
approximately 1cm of washed and sterilized sand collected in Argelès-sur-
Mer, France100. Filtered and sterilized (through UV light) artificial sea water 
(ASW) with a final salt concentration of 38g/L was pumped every day into 
each tank, during a controlled time period to renew about 1L of ASW and 
continuous aeration was supplied100. The facility was equipped with air 
temperature control set to 18ºC and the ASW flushed into the tanks had a 
temperature of approximately 16ºC, allowing a relatively constant water 
temperature of 17-18ºC inside the tanks. The animals were kept in a 
spring-like day/night light period (14 hours of light versus 10 hours of 
absolute darkness) in an inverted illumination cycle100. Animals were fed 
with artificial food twice a week100. 
Spawning was induced by 36 hours of thermal shock at 23ºC as 
previously described96,97,100. Males and females with full gonads were 
selected (15-20 animals) and put together during the thermal shock in 
tanks with reduced amounts of sand. The thermal shock was induced one 
hour after the lights turned on and 36 hours thereafter (1 hour before the 
lights were turned off) each animal was transferred to an individual clear 
plastic cup containing about 10 mL of filtered ASW. After spawning, the 
gametes were collected and fertilization took place in Petri-dishes containing 
filtered ASW. After fertilization, the embryos were raised in filtered ASW, in 
the dark, at 19ºC. 
 
iii. Pharmacological Treatments (RA and BMS009) 
Treatments with all-trans RA (dissolved in DMSO) and BMS009, a RA 
antagonist (dissolved in DMSO), were performed at the late blastula/early 
17 
 
gastrula stage, in a small Petri-dish at a final concentration of 10-6M in 
filtered ASW. Simultaneously, embryos were treated with DMSO (1:1000) 
alone in a different dish, as a control102,109. After hatching, at the early 
neurula stage, embryos were transferred to untreated filtered ASW and 
allowed to develop further101,104. During the next two days, developmental 
stages (controls, RA-treated and BMS009-treated) were fixed at frequent 
intervals in 4% paraformaldehyde in MOPS buffer (0.1M Mops, 0.5M NaCl, 
2mM MgSO4, 1mM EGTA, pH 7.4) for in situ hybridization
110. After fixation 
overnight at 4ºC, the embryos were washed with 70% ethanol and stored in 
70% ethanol at -20ºC. 
 
iv. In Situ Hybridization (ISH) 
Embryos at different developmental stages were fixed using a similar 
protocol as described above. For each of the Cyp26 genes of B. 
lanceolatum, previously cloned in our lab, antisense riboprobes were 
synthesized accordingly to Holland et al.111 and ISH was performed as 
described by Yu and Holland110. ISH was performed in embryos 
representative of all stages of development (blastula; early, mid and late 
gastrula; early, mid, and late neurula; late embryos and different larval 
stages) and ISH preparations were photographed as whole mounts under 
DIC (differential interference contrast) settings. 
 
v. RNA Extraction and cDNA Synthesis 
RNA extraction was carried out as described by Yu and Holland112. The 
A260/280 ratios and the concentration of all the RNAs prepared were 
measured using a NanoDrop® (LabTech®) system, and the RNA integrity 
was checked by electrophoresis on a 1% agarose gel. 
The cDNAs were synthesized with reverse transcription kit 
(SuperScript®III – Invitrogen®) and the reaction was carried out as 
indicated by the manufacturer.  
 
vi. Quantitative RT-PCR and Data Analysis 
The cDNA was used as template for quantitative real-time PCR assay 
using primers specific for B. lanceolatum glyceraldehyde-3-phosphate 
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dehydrogenase (GAPDH), Elongation Factor 1-α (EF1α), 18S rRNA, β-actin, 
RAR, Cyp26-1, Cyp26-2 and Cyp26-3 with the QuantiTect SYBR Green PCR 
reagents (QIAGEN) and the DNA Engine Opticon system (MJ Research) 
according to the instructions of the manufacturer. The primer sequences 
used for GAPDH were 5’-AGGGTCTCATG ACCACGGTA-3’ and 5’-
TTCTTCAGTCGG-CAGGTCAG-3’; for EF1α, 5’-ATGG GCAAGGAAAAGCTTCACA 
TC-3’ and 5’-TCACTTCTTCTTCCCGCCGGCAG-3’; for 18S rRNA, 5’-
CATCAGCCATGCCTAAGGTT-3’ and 5’-CTATTCCTTGCTGG CCATGT-3’; for β-
actin, 5’-TTACAATGGAAGACGATGTTGC-3’ and 5’-ATCGTTAGCTCCTGACAA 
GCTC-3’; for RAR, 5’-GTCTGCCATCGGGATAAGAA-3’ and 5’-
GCCTCTCTGACCGTGGTTAT; for Cyp26-1, the primers were 5’-CAAGAC 
GAGGACGAGATCAGTAG-3’ and 5’-CTTCTCGTGGATGTGACGTTTTA-3’; for 
Cyp26-2, 5’-CAACACCTCACTTTCCTCTTCAC and TCTTCCTCTGAATGTG 
GTTCATC; and for Cyp26-3, 5’-CAAGAGAGATGTCGTTTCAGAGC-3’ and 5’-
CTTCCAACCATTGGTCGATACT-3’. The reaction conditions consisted of 95ºC 
for 15 minutes followed by 40 cycles of 95ºC for 30 seconds, 55ºC for 30 
seconds, and 72ºC for 45 seconds. Each reaction was performed in 
triplicate. After multiple assays, only 18S rRNA was selected as reference 
for internal standardization of the starting quantity of RNA. This choice was 
based on our observations in response to the different treatments and is 
also supported by a recent publication113. 
Data were quantified using the 2-ΔΔCT method. The experimental data 
were then pooled, analyzed and presented in relation to the relative 
quantity of mRNA for RAR in a control situation as mean +/- standard error 
(SE). 
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III. RESULTS 
i. Cyp26 Phylogenetic Analysis 
With the aim to better understand the origin of RA signaling in the 
diversification of protostomes and deuterostomes as well as to reveal the 
evolutionary relationships between Cyp26 genes and the three Cyp26s 
genes identified in amphioxus (both B. floridae114 and B. lanceolatum), we 
conducted a phylogenetic analysis including Cyp26 amino acid sequences 
from different animal groups: mollusks (L. gigantea), annelids (C. teleta), 
echinoderms (S. purpuratus), hemichordates (S. kowalevskii), vertebrates 
(G. aculeatus, T. nigroviridies, O. latipes, D. rerio, X. tropicalis, G. gallus, M. 
domestica, H. sapiens and M. musculus), tunicates (C. intestinalis and C. 
savignyi) and cephalochordates (B. floridae and B. lanceolatum). Cyp51, the 
only family of cytochrome P450 that is widely distributed in all the different 
biological kingdoms115, was used as an outgroup (Fig. 4).  
In our analysis, the three amphioxus Cyp26 genes (Cyp26-1, Cyp26-2 
and Cyp26-3) are paired together in a strongly supported branch suggesting 
a common evolutionary origin (Fig. 4). Similarly, all the Cyp26 genes of 
vertebrates (Cyp26A1, Cyp26B1 and Cyp26C1) show a similar relationship, 
in a way that all the Cyp26A1s, Cyp26B1s and Cyp26C1s are well organized 
in very robustly supported groups (Fig. 4). The Cyp26 lineages of 
cephalochordates and vertebrates are grouped in two different branches, 
suggesting the evolutionary divergence of the three Cyp26s in amphioxus is 
independent of those in vertebrates. The duplications of Cyp26 genes in 
cephalochordates and vertebrates are thus likely independent events. 
The invertebrate groups included in the analysis (mollusks, annelids, 
echinoderms, hemichordates and tunicates) group together in a poorly 
supported arrangement (Fig. 4). This kind of assemblage can be explained, 
most likely, as a phenomenon associated with methodological artifacts, 
called long-branch attraction116. 
Taken together, our data reveal in detail the relationship between 
amphioxus and vertebrates in terms of Cyp26 divergence, however it 
exposes some weakness resolving the evolutionary origins of this gene 
family. 
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ii. Cyp26 Expression Profile During Amphioxus Development 
Whole mount in situ hybridization (ISH) was used to assess the 
expression pattern of the three Cyp26 genes of B. lanceolatum during 
development. Developmental series were obtained from shortly after 
fertilization until the 3-day larval stage (Fig. 5, 6 and 7). As a technical 
comment concerning the expression patterns, representative signaling for 
Cyp26-1 and Cyp26-3 were very difficult to obtain, in a way that the 
staining procedure was carried out for several days.  
Cyp26-1 
ISH results for Cyp26-1 probe exhibit no detectable transcription signal 
from fertilization to mid gastrulation (data not shown). The Cyp26-1 gene 
expression is first detected at the late gastrula stage (15 hours post-
fertilization or hpf) when the expression is weak in the mesoderm (Fig. 5A, 
B). Until the early neurula stage, 20 hpf, the signal is expanded in the 
mesoderm, mainly associated with somite structures (Fig. 5C, D). The 
Cyp26-1 signal becomes more evident at 24hpf (mid neurula stage) 
preserving the mesodermal predominance (Fig. 5E, F). At 36hpf, late 
embryo stage, the signal is rather weak and sparse associated with 
mesodermal structures (Fig. 5G). At 48hpf, the early larva exhibits a weak 
mesoderm associated signal (Fig. 5H), which is completely lost in the 
following stages (data not shown).  
Cyp26-2 
Distinct from Cyp26-1, Cyp26-2 displays a much more complex and 
conspicuous developmental expression profile. The first appearance of 
Cyp26-2 expression is at the mid gastrula stage (9 hpf). At this stage, the 
Fig. 4 – Cyp26 phylogenetic analysis. Rooted maximum likelihood tree of Cyp26 using 
Cyp51 as outgroup.  represents branches of low bootstrap support (lower than 70%), 
where numbers showed correspond to bootstrap values, and  represents branches fully 
supported (100%). B.flo, Branchiostoma floridae; B.lan, Branchiostoma lanceolatum; C.int, 
Ciona intestinalis; C.sav, Ciona savignyi; C.tel, Capitella teleta; D.rer, Danio rerio; G.acu, 
Gasterosteus aculeatus; G.gal, Gallus gallus; H.sap, Homo sapiens; L.gig, Lottia gigantea; 
M.dom, Monodelphis domestica; M.mus, Mus musculus; O.lat, Oryzias latipes; S.kow, 
Saccoglossus kowalevskii; S.pur Strongylocentrotus purpuratus, T.nig, Tetraodon 
nigroviridies; X.tro, Xenopus tropicalis. 
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Fig. 5 – Expression of Cyp26-1 in amphioxus (Branchiostoma lanceolatum) 
development. Anterior side to left and, excepting A, D and F, dorsal up. Lateral views in 
B, C, E, G, H and A, D, F viewed from dorsal side. Scale bar 50 µm. (A,B) late gastrula – 
15hpf; (C,D) early neurula – 20hpf; (E,F) mid neurula – 24hpf; (G) late embryo – 36hpf; 
(H) early larva – 48hpf. 
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Fig. 6 – Expression of Cyp26-2 in amphioxus (Branchiostoma lanceolatum) 
development. Anterior side to left and, excepting B, E and G, dorsal up. Lateral views in 
A, C, D, F, H, I, J, K and B, E, G viewed from dorsal side. Scale bar 50µm. (A) mid 
gastrula – 9hpf; (B,C) late gastrula – 15hpf; (D,E) early neurula – 20hpf; (F,G) mid 
neurula – 24hpf; (H) late embryo – 32hpf; (I) late embryo – 36hpf; (J) early larva – 
48hpf; larva – 72hpf. 
 
Fig. 7 – Expression of Cyp26-3 in amphioxus (Branchiostoma lanceolatum) 
development. Anterior side to left and, excepting A, D and F, dorsal up. Lateral views in 
B, C, E, G, H and A, D, F viewed from dorsal side. Scale bars 50µm. (A,B) late gastrula – 
15hpf; (C,D) early neurula – 20hpf; (E,F) mid neurula – 24hpf; (G) late embryo – 36hpf; 
(H) early larva – 48hpf. 
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signal is localized conspicuously around the blastopore (Fig. 6A). At late 
gastrula, the blastopore signal is still present although less prominently and 
a new wave of signaling is observed in the region that corresponds to 
mesoderm (Fig.6B, C). Later, at 20hpf, both expression domains are still 
present (Fig. 6D, E). The signal associated with the blastopore maintains its 
posterior identity, but exhibits only weak expression. In contrast, the 
mesodermal signal is expanded and in this region very strong expression is 
also detectable in the other tissue layers. At mid neurula stages, the 
expression in the anterior region is preserved and it displays a strong 
signal, mostly present in the mesoderm. At this stage the neuroectodermal 
region also expresses Cyp26-2. Furthermore, a posterior signal appears 
associated with the forming tail bud and includes the posteriormost 
ectoderm that already expressed the gene (Fig. 6F, G). Shortly after the 
process of the neurulation (32hpf), gene expression is restricted to posterior 
ectodermal structures as well as to the anterior region of the embryo. This 
latter pattern, thus represents a signal reduction and a more tissue-specific 
outline when compared to previous developmental stages (Fig. 6H, I). At 
larval stages (48hpf and 72hpf) the ectodermal region of the tail bud still 
expresses Cyp26-2. The expression of Cyp26-2 in the anterior region is also 
maintained with a tendency for tissue-specification, associated here with 
the pharyngeal ectoderm, mesoderm and endoderm (Fig. 6J, K). Due to the 
complexity of the general signaling outline, further analyses are required to 
confirm the tissue specificity during development. 
 Cyp26-3 
The gene expression profile of Cyp26-3 displays a rather similar 
distribution, both in space and time, as Cyp26-1. From the first cellular 
divisions until mid gastrulation no expression is detectable (data not 
shown). Expression commences at the late-gastrula stage with a faint signal 
in the mesoderm (Fig. 7A, B). Thereafter, at the early neurula stage, the 
gene expression expands and is localized in the somites (Fig. 7C, D). 
Amphioxus embryos of 24hpf show an apparent weakening of the signal, 
albeit keeping the initial somite localization (Fig. 7E, F). In the late embryo, 
the gene expression of Cyp26-3 exhibits a weak and disperse pattern (Fig. 
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7G) that is almost lost in the early larva (Fig.7H). Finally, no signal is found 
at later larval stages (data not shown). 
 
iii. Quantitative RT-PCR Combined with RA and BMS009 
Treatments 
Quantitative RT-PCR was used to quantify expression of RAR, Cyp26-1, 
Cyp26-2 and Cyp26-3 as two different stages of amphioxus development: 
at 20hpf (neurula) and at 48hpf (larva). To obtain an idea of the 
fluctuations of gene expression levels induced by variations of RA signaling 
levels, quantitative RT-PCR analysis was coupled with pharmacological 
treatments with RA and BMS009 (the RA antagonist). The data obtained 
were normalized to the level of RAR in a control situation, with RAR being a 
gene shown to be under the direct control of RA in amphioxus. 
In a control situation, qRT-PCR results reveal that the effective 
expression level of Cyp26-1 and Cyp26-3 is much lower that of Cyp26-2 
and RAR at 20hpf (Fig. 8A, red bars). Under these conditions, Cyp26-2 
expression is generally higher than that of RAR and about 5000 times 
higher levels than the two other Cyp26 genes (Annex I). When embryos 
were treated exogenously with RA at 20hpf, RAR expression is increased 2.4 
fold (Annex I). Consistently, Cyp26-2 exhibits a similar fold increase of 
expression. In great contrast, both Cyp26-1 and Cyp26-3 show a huge 
increase in expression levels: respectively, 350 and 26 fold (Fig. 8A, green 
bars and Annex I). The addition of BMS009, an RA antagonist, induces a 
reduction of RAR and Cyp26-3, but on different scales, 2 and 20 fold 
respectively (Fig. 8A, blue bars and Annex I). Interestingly, under the 
influence of BMS009, the overall transcription of Cyp26-1 and Cyp26-2 
remain almost unaltered when compared to the control situation (Fig. 8A, 
blue bars and Annex I). 
As a later stage of development, 48hpf, small differences in the 
expression profiles of the Cyp26 genes can be noticed. In a control 
situation, the different levels of expression between Cyp26-1 and Cyp26-3 
(low) and Cyp26-2 and RAR (high) are still evident (Fig. 8B, red bars). That 
said, the magnitude of the difference is distinct from the situation at 20hpf, 
with the expression of Cyp26-1 and Cyp26-3 being only about 4 and 8 
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  A 
B 
Fig. 8 – Relative expression of RAR, Cyp26-1, Cyp26-2 and Cyp26-3 in 
amphioxus (Branchiostoma lanceolatum) embryos. (A) Expression levels at 20hpf 
and (B) at 48hpf in a control situation, DMSO 1:1000 (red bars), treatments with 10-6M 
RA (green bars) and treatments with 10-6M BMS009, a RA antagonist (blue bars). Data 
are expressed as the mean fold change (means +/- SE, n=3) relative to RAR in the 
control, for detailed check Annex I. 
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times lower than respectively, that of RAR. In addition, expression of 
Cyp26-1 and Cyp26-3, when compared to Cyp26-2, is only around 2.5 and 
5 times lower, respectively (Fig. 8B, red bars and Annexe I). Treatments 
with 10-6M RA induce drastic changes in the expression profiles of the 
genes. The reference gene RAR shows a 3.6 fold increase of expression, 
while Cyp26-2 only shows an increase of 1.6 fold. When compared to the 
neurula stage, the increase of expression of Cyp26-1 and Cyp26-3 is less 
dramatic (101 and 5.2 total fold, respectively), albeit still impressive (Fig. 
8B, green bars and Annexe I). In the experiments carried out with the RA 
antagonist, the general decrease of expression of the Cyp26 genes and of 
the RAR is confirmed. The expression of RAR is reduced almost 3 times, 
Cyp26-1 is reduced roughly 6 times and Cyp26-3 shows a 123 fold 
reduction in its expression levels. Curiously, Cyp26-2 gene expression is 
almost unaltered after treatment with BMS009 (Fig. 8B, blue bars and 
Annex I). 
Together, these quantitative results illustrate that each of the three 
amphioxus Cyp26 genes responds differently to alterations of RA signaling 
levels. Although, the responses of Cyp26-1 and Cyp26-3 are more similar to 
each other than to the response of Cyp26-2. Ultimately, each of the three 
genes seems to contribute to the endogenous balance of RA. 
 
iv. Cyp26 Expression Pattern Induced by Pharmacological 
Treatments  
To address the spatial arrangement of Cyp26 gene expression changes 
induced by pharmacological treatments ISH was performed on amphioxus 
embryos collected at 20hpf and 48hpf (the same stages used in qRT-PCR 
analysis). Under control conditions (treatment with DMSO 1:1000), the 
expression profile for Cyp26 genes are unaltered relative to the expression 
pattern described (Fig. 9B, E, H, K, N, Q). Cyp26-1 expression increases 
significantly when exogenous RA is applied (as indicated by qRT-PCR) but 
the signal is not uniformly distributed throughout the embryo with certain 
regions showing less intense staining, both at 20hpf and 48hpf (Fig. 9A, D). 
Due to the intensity of the staining, further analyses must be carried out to 
assess the tissue specificity of the signal. On the other hand, treatments 
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  Fig. 9 – Expression of amphioxus (Branchiostoma lanceolatum) Cyp26s in 
treated embryos. Anterior side to left and dorsal up, all lateral views. (A-F) expression 
of Cyp26-1, (G-L) expression of Cyp26-2, (M-R) expression of Cyp26-3. Pharmacological 
treatments as follows: 10-6M RA (A, D, G, J, M, P), DMSO control (B, E, H, K, N, Q) and 
10-6M BMS009, a RA antagonist (C, F, I, L, O, R) at 20hpf (A-C, G-I, M-O) and 48hpf (D-
F, J-L, P-R). Scale bars 50µm. 
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with RA antagonist lead to a general decrease of the signal. This reduction 
is less evident at 20hpf than at 48hpf, where almost no Cyp26-1 staining is 
visible (Fig.9C, F). 
The Cyp26-2 signal obtained in embryos treated with RA is also 
expanded relatively to the control, albeit less extensively than Cyp26-1. At 
20hpf, Cyp26-2 expression is strongly increased in the posterior and 
anterior regions of the embryo. The signal is most conspicuous in the 
dorsal, anterior and posterior of the embryo (Fig. 9G). At the larval stage 
the influence of RA has similar effects since in the anterior end and 
posterior regions of the embryo the signal is broadly detectable (Fig. 9J). 
BMS009 treatments have a quite evident effect on the Cyp26-2 expression 
pattern: the posterior signal is completely lost, both at 20hpf and 48hpf, 
whether the transcription in the anterior region is almost unaffected (Fig. 
9I, L).  
The Cyp26-3 expression profile is also affected by excess of RA. The 
expression of this gene is strongly increased at 20hpf being somehow 
similar to the pattern shown for Cyp26-2 transcription (Fig. 9G vs M). 
Furthermore, at 48hpf, RA treatments induce a broad Cyp26-3 expression 
across the embryo (Fig. 9P). As expected, in embryos treated with RA 
antagonist the Cyp26-3 signal is weaker than in the control at the neurula 
stage and almost undetectable at larval stages (Fig. 9O, R). 
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IV. DISCUSSION 
i. Amphioxus Cyp26s are a Lineage-Specific Duplicates 
RA signaling was long thought to be vertebrate-specific, but studies 
carried out in tunicates, cephalochordates, hemichordates and echinoderms 
have yielded a new perspective, where the RA signaling cascade is present 
during development of all deuterostomes11,117. Moreover it has also been 
shown that the basic RA signaling components are present in 
lophotrocozoans7. Thus, these data suggest the presence of RA signaling in 
the Urbilateria, the last common ancestor of protostomes and 
deuterostomes. Moreover, the absence of RA signaling components in the 
ecdysozans studied, thus far suggests that RA signaling might have 
secondarily been lost in this lineage. Using this idea as basis, we assayed 
genomes of different species for Cyp26 orthologs and we used them for a 
detailed phylogenetic analysis. 
We thus established an evolutionary relationship between Cyp26 genes 
from different groups. We revealed that Cyp26 genes from amphioxus 
originated as a lineage-specific duplication. Our phylogenetic tree does not 
fully support this notion, because of the low bootstrap values associated 
with the division between the Cyp26 genes from cephalochordates and the 
vertebrate Cyp26 genes. Nevertheless, we found that the amphioxus cluster 
of Cyp26 genes is strongly supported. Within this cluster, the division 
between the two species of the Branchiostoma genus is also strongly 
supported, which suggests that the lineage-specific duplication events 
predate the speciation event in the Brachiostoma genus. 
Lineage specific amplification of particular gene families in amphioxus 
were previously described111 and it would be interesting to assess whether 
these duplications are also ancient cephalochordate-specific events or have 
recent duplications in the Branchiostoma genus. 
Moreover, abundant and more accurate genomic information can be 
obtained about vertebrate groups, also reflected in our tree thus the 
corresponding vertebrate cluster exhibits a greater level of detail. Thus it 
seems a strong correlation exists between the different paralogs in 
vertebrates, in other words there is a strong phylogenetic association 
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between all the Cyp26A1s, all the Cyp26B1s and all the Cyp26C1s118, which 
is reflected in three independent clusters that are very well supported. This 
relationship can be proposed as a recapitulation of the two events of whole 
genome duplication that occurred in the stem vertebrate lineage (1R and 
2R)119, drastic genomic events thought to have crucially contributed to the 
refinement of developmental processes, through an overall increase in gene 
numbers119-121. Combining the data obtained and the overall functions 
described for different Cyp26 paralogs in vertebrates30,32, one may suggest 
that Cyp26 genes represent a good study object for assessing 
neofunctionalization of genes that might have allowed the diversification of 
RA functions during embryogenesis. 
The unresolved branches of the remaining groups in the tree raise some 
interesting possibilities about the early diversification of the RA signaling 
cascade. As a matter of fact, these invertebrates groups exhibit a peculiar 
trait, with the presence, excepting S. purpuratus, of two different Cyp26 
sequences in each group. Similarly to what has occurred in the 
cephalochordate lineage and despite the phenomenon of long-branch 
attraction, these duplication might indeed represent specific duplications of 
Cyp26 genes. These independent duplications might have occurred 
independently in each lineage or, alternatively, might have occurred early in 
the bilaterian lineage followed by subsequent lineage-specific losses. The 
addition of more data will certainly help to resolve this question. 
Be this as it may, this predisposition to Cyp26 duplication reinforces the 
notion that rigorous control of RA availability is a process that evolved along 
with the developmental functions of RA signaling. 
 
ii. Branchiostoma lanceolatum Cyp26 Genes Display 
Complex Expression Patterns, in both Time and Space 
In vertebrates, the Cyp26 family is composed of three paralogs 
(Cyp26A1, Cyp26B1 and Cyp26C1). All three genes albeit expressed in 
different tissue specific patterns30,31 are regulated by RA. Cyp26A1 
expression starts during the gastrula stage in mouse, chick, frog and 
zebrafish. The expression pattern of Cyp26A1 in these organisms is complex 
and very dynamic53. Loss of Cyp26A1, in mice leads to death before the first 
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postnatal day with mutants presenting posteriorized hindbrain and 
vertebrae as well as severe caudal truncations122. Cyp26B1 expression 
appears later in development and is restricted to specific hindbrain 
domains30. Later, it plays a critical role in regulation of RA signaling during 
limb specification123. Cyp26C1 expression has been described in the amnion 
and in hindbrain rhombomers30. Mice lacking Cyp26C1 are viable and do not 
show severe anatomical abnormalities, suggesting some individual 
redundancy with the other two paralogs124. In contrast, CYP26A1 and 
CYP26C1 double mutants display a stronger phenotype when compared to 
CYP26A1 single mutants and loss of RALDH2 function induces a partial 
rescue of the phenotype, confirming that Cyp26 mutant malformations are 
due to elevated levels of RA124. 
Conversely, the Cyp26 genes in amphioxus show peculiar expression 
patterns. Thus, the only amphioxus Cyp26 gene which displays a complex 
spatiotemporal pattern and that is expressed in all tissue layers seems to be 
Cyp26-2. Expression of this gene is found around the blastopore during 
gastrula, with this signal being carried over into posterior structures. This 
posterior expression domain is reminiscent of the posterior expression of 
the vertebrate Cyp26A130. In amphioxus, Cyp26-2 might thus similarly be 
involved in the specification of the tail bud and might thus also be 
responsible for posterior extension of the body axis of the amphioxus tail 
bud125. Curiously, the posterior Cyp26-2 signal displays a decrease of 
intensity during gastrulation and a strong increase thereafter. These two 
signal waves of Cyp26-2 posteriorly might suggest different functional roles 
of this gene controlled in a time-specific manner, where the initial domain 
might act to maintain RA-free environment around the blastopore, while the 
second domain might be required to establish a zone of RA degradation 
associated with the tail bud. 
In parallel, a mesodermal Cyp26-2 signal appears up during late 
gastrulation and subsequently it appears in all the tissue layers as the 
anterior end of the embryo. Then, the anterior signaling seems to be 
reduced and the expression is finally restricted to anterior domains 
associated with pharynx and posterior domains associated with the tail bud. 
This Cyp26-2 transcription profile, thus suggests roles in the formation of 
pharyngeal structures, such as the mouth, and possibly in formation of 
34 
 
posterior structures. This expression pattern is consistent with observations 
made using pharmacological treatments inducing Cyp26 inhibitors, showing 
pharyngeal defects and tail fin formation defects (data not shown). It might 
be that this expression creates a RA-fee environment anteriorly that is 
required for the proper patterning of the embryo. In particular, the strong 
mesodermal expression of Cyp26-2 points to the creation of a mesodermal 
RA-free buffer zone located between the neural ectoderm dorsally and the 
endoderm ventrally, which might be a crucial component of the RA signaling 
machinery in the amphioxus, allowing independent RA-dependent AP 
patterning of the CNS and the pharyngeal endoderm. 
Surprisingly, both Cyp26-1 and Cyp26-3 show an overall transcription 
pattern that is very similar: weak and restricted to the mesoderm. In fact, 
expression of these genes seems to colocalize with some domains if Cyp26-
2 expression. Cyp26-1 and Cyp26-3 might function only in the same cellular 
environment as Cyp26-2 without any additional functional domains of their 
own. The function of Cyp26-1 and Cyp26-3 might thus be limited during 
embryogenesis to a subset of domains also expressing Cyp26-2. 
Collectively, the Cyp26 gene expression data disclose a quite different 
scenario in cephalochordates when compared with vertebrates, since only 
Cyp26-2 seems to be involved in tissue-specific patterning, acting as the 
Cyp26 master gene in development. That said, the complex arrangement of 
Cyp26 degradation zones during amphioxus development is consistent with 
the pattern of Cyp26 expression observed in vertebrates, suggesting an 
evolutionarily conserved role for RA degradation as a powerful mechanism 
for developmental patterning in amphioxus and vertebrates. Future studies 
will need to address in detail the tissue specificity of Cyp26 in amphioxus  
 
iii. Cyp26s Gene Expression is Dependent of RA Signaling 
Hundreds of genes have shown to be regulated by RA under various 
physiological conditions 28,42. Thus, the first evidence of the existence of the 
Cyp26 family in mammals also came with the in vitro evidence that RA is a 
potent inducer of CYP26 gene expression126. Further studies reported a 
dose-dependent relationship between the treatment with RA of vitamin A 
deficient and an increase of Cyp26A1 mRNA levels127,128. CYP26B1 mRNA 
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levels in the liver and lung also increase after RA treatments30. In contrast, 
little is known about the expression profile of CYP26C1 under 
pharmacological conditions30. The influence of RA on Cyp26 expression was 
also addressed in vertebrate embryos, revealing tissues where the Cyp26 
genes are upregulated and others where these genes are downregulated. 
For instance, in zebrafish and chick, Cyp26A1 and Cyp26B1 are upregulated 
in the cranial mesoderm, while Cyp26C1 is dowregulated53. Additionally, in 
mice Cyp26A1 is simultaneously upregulated in cranial ganglia and 
downregulated in the tail bud53. These patterns of expression reveal that RA 
dependence of the Cyp26 genes is defined in a tissue-specific manner. 
The Cyp26 genes of B. lanceolatum seem to show a consistent 
upregulation in presence of RA and a downregulation when treated with a 
RA signaling antagonist, BMS009. Even so, the three genes exhibit different 
sensibilities to RA signaling levels. Moreover, the reactivity also seems to 
depend on the developmental stage. Thus, in presence of RA, we found that 
both Cyp26-1 and Cyp26-3 expression are strongly increased in neurula 
(20hpf) and larva (48hpf), with the response of Cyp26-1 being stronger 
than that of Cyp26-3. In contrast, Cyp26-2 levels increase significantly, but 
not dramatically, upon RA stimulation at both 20hpf and 48hpf. 
Conversely when embryos are treated with BMS009 the reduction of 
expression levels are dramatic for Cyp26-3, but not for Cyp26-1 and Cyp26-
2. 
Given these results, we could argue that Cyp26-1 and Cyp26-3 
expressions are more sensible to RA signaling variations than Cyp26-2, and 
that these genes might hence participate in an intricate and efficient 
mechanism of buffering the endogenous availability of RA, hence avoiding 
potentially teratogenic effects induced by RA excess or deficiency. This 
hypothesis is supported by the expression patterns of Cyp26-1, Cyp26-2 
and Cyp26-3 observed after RA and BMS009 treatment, with Cyp26-1 
expression, for example, induced globally in all the tissue layers, both 20hpf 
and 48hpf. These data further indicate that Cyp26-1 might be of particular 
importance in mediating this protective function of the amphioxus Cyp26s. 
Moreover, the results of the in situ hybridization experiments with the 
Cyp26 genes coupled to pharmacological treatments also revealed that the 
expression pattern changes of the three amphioxus Cyp26 genes following 
36 
 
treatments were not uniform. Thus, Cyp26 expression follows the 
treatments is modified differentially for each gene. While Cyp26-1 
expression is indeed upregulated globally by RA in all the tissue layers and 
almost completely dowregulated by BMS009, RA seems to preferentially 
upregulate Cyp26-2 and Cyp26-3 expression anteriorly, posteriorly and 
dorsally, leaving the ventral region of the 20hpf neurula and the 48hpf larva 
more or less unaffected. Albeit less conspicuously, the RA antagonist also 
preferentially reduces the anterior and posterior expression territories of 
Cyp26-2 e Cyp26-3. 
Taken together, in amphioxus there seem to exist two Cyp26 mediated 
mechanism to regulate endogenous RA signaling levels: a global protection 
mechanism, mediated by Cyp26-1, and possibly Cyp26-3, and a tissue 
specific protection mechanism, controlled by Cyp26-2 and maybe Cyp26-3, 
that might parallel the tissue-specific functions of the vertebrate paralogs53. 
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V. CONCLUDING REMARKS 
In this work, I addressed the evolutionary and developmental 
perspectives arising from the study of Cyp26 enzymes, the main RA 
degradation enzymes in the cephalochordate amphioxus, although 
interesting leads for the relationships between Cyp26 functions in 
amphioxus and vertebrates have emerged, a detailed functional description 
of the amphioxus genes still remain elusive. Thus, much more work still 
needs to be done to follow up on the initial findings and address, for 
example, the question of tissue-specificity of Cyp26 functions, both in terms 
of patterning and in terms of protective effects. The first step should be 
histological sections that will allow to assess the exact tissue-specific 
distribution of the Cyp26 genes, during normal development and after 
pharmacological treatments103,129. Moreover, functional studies of the 
amphioxus Cyp26 genes will provide further information about the dynamic 
process of RA degradation in amphioxus. For example, global 
pharmacological inhibition of Cyp26 function can yield insights into the 
functional roles of the three amphioxus Cyp26 enzymes, while gene-specific 
knockdown (morpholino oligonucleotides) and overexpression (mRNA 
injection)130 studies will reveal the exact functions of each of the three 
Cyp26 genes during embryonic development. These injection-based 
experiments, which are now available in amphioxus, will thus reveal 
whether amphioxus Cyp26 genes function induced both in global RA 
buffering and tissue-specific RA patterning during development.  
 
In summary, this study presents the first experimental evidence for 
developmental roles of Cyp26 enzymes in amphioxus, which brought to light 
possible conserved and divergent features of RA metabolism in developing 
amphioxus embryos. In evolutionary terms the data here shown suggest 
that tissue-specific patterning functions of Cyp26 were already present in 
the last common ancestor of amphioxus and vertebrates. In contrast, unless 
demonstrated in vertebrates, global protective mechanisms are either an 
amphioxus-specific innovation or have secondarily been lost in the lineage 
leading to extant vertebrates. 
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ANNEXE 
Annex I – Relative expression of RAR, Cyp26-1, Cyp26-2 and Cyp26-3 in 
amphioxus (Branchiostoma lanceolatum) embryos. Detailed qRT-PCR data (Fig. 8). 
Control, treatment with DMSO 1:1000; RA, treatment with 10-6M RA; BMS009, treatment 
10-6M BMS009, a RA antagonist. Mean is exhibited relative to RAR in the control (n=3); 
Fold increase of each gene was determined by dividing mean results in the trial situation 
(RA, BMS009) by the mean results of the control. SE – standard error; n/a – not 
applicable.  
